| How the immune system shapes atherosclerosis: roles of innate and adaptive immunity P Roy, M Orecchioni, K Ley Nature Reviews Immunology 22 (4), 251-265, 2022 | 231 | 2022 |
| Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production M Orecchioni, K Kobiyama, H Winkels, Y Ghosheh, S McArdle, Z Mikulski, ... Science 375 (6577), 214-221, 2022 | 96 | 2022 |
| The NF-κB activating pathways in multiple myeloma P Roy, UA Sarkar, S Basak Biomedicines 6 (2), 59, 2018 | 84 | 2018 |
| Stimulus-selective crosstalk via the NF-κB signaling system reinforces innate immune response to alleviate gut infection B Banoth, B Chatterjee, B Vijayaragavan, MVR Prasad, P Roy, S Basak Elife 4, e05648, 2015 | 59 | 2015 |
| Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB: p50 NFκB pathway P Roy, T Mukherjee, B Chatterjee, B Vijayaragavan, B Banoth, S Basak Oncogene 36 (10), 1417-1429, 2017 | 47 | 2017 |
| Kindlin-3 recruitment to the plasma membrane precedes high-affinity β2-integrin and neutrophil arrest from rolling L Wen, A Marki, P Roy, S McArdle, H Sun, Z Fan, AR Gingras, ... Blood, The Journal of the American Society of Hematology 137 (1), 29-38, 2021 | 37 | 2021 |
| Role of the NF-κB system in context-specific tuning of the inflammatory gene response M Chawla, P Roy, S Basak Current opinion in immunology 68, 21-27, 2021 | 33 | 2021 |
| A TNF‐p100 pathway subverts noncanonical NF‐κB signaling in inflamed secondary lymphoid organs T Mukherjee, B Chatterjee, A Dhar, SS Bais, M Chawla, P Roy, A George, ... The EMBO Journal 36 (23), 3501-3516, 2017 | 27 | 2017 |
| Single cell transcriptomics and TCR reconstruction reveal CD4 T cell response to MHC-II-restricted APOB epitope in human cardiovascular disease R Saigusa, P Roy, A Freuchet, R Gulati, Y Ghosheh, ... Nature cardiovascular research 1 (5), 462-475, 2022 | 19 | 2022 |
| Opportunities for an atherosclerosis vaccine: from mice to humans P Roy, AJ Ali, K Kobiyama, Y Ghosheh, K Ley Vaccine 38 (28), 4495-4506, 2020 | 18 | 2020 |
| Immune differentiation regulator p100 tunes NF-κB responses to TNF B Chatterjee, P Roy, UA Sarkar, M Zhao, Y Ratra, A Singh, M Chawla, ... Frontiers in immunology 10, 997, 2019 | 17 | 2019 |
| Combined protein and transcript single-cell RNA sequencing in human peripheral blood mononuclear cells J Vallejo, R Saigusa, R Gulati, SS Armstrong Suthahar, V Suryawanshi, ... BMC biology 20 (1), 193, 2022 | 15 | 2022 |
| Identification of human exTreg cells as CD16+ CD56+ cytotoxic CD4+ T cells A Freuchet*, P Roy*, SS Armstrong, M Oliaeimotlagh, S Kumar, ... Nature Immunology, 1-14, 2023 | 13 | 2023 |
| Sex differences in coronary artery disease and diabetes revealed by scRNA-Seq and CITE-Seq of human CD4+ T cells R Saigusa, J Vallejo, R Gulati, SSA Suthahar, V Suryawanshi, ... International journal of molecular sciences 23 (17), 9875, 2022 | 10 | 2022 |
| Immunodominant MHC-II (major histocompatibility complex II) restricted epitopes in human apolipoprotein B P Roy, J Sidney, CS Lindestam Arlehamn, E Phillips, S Mallal, ... Circulation research 131 (3), 258-276, 2022 | 10 | 2022 |
| Titration of 124 antibodies using CITE-Seq on human PBMCs FS Nettersheim, SS Armstrong, C Durant, R Blanco-Dominguez, P Roy, ... Scientific reports 12 (1), 20817, 2022 | 6 | 2022 |
| Autoimmune regulator (AIRE) deficiency does not affect atherosclerosis and CD4 T cell Immune tolerance to apolipoprotein B FS Nettersheim, S Braumann, K Kobiyama, M Orecchioni, M Vassallo, ... Frontiers in Cardiovascular Medicine 8, 812769, 2022 | 3 | 2022 |
| Combined protein and transcript single cell RNA sequencing reveals cardiovascular disease and HIV signatures J Vallejo, R Saigusa, R Gulati, Y Ghosheh, CP Durant, P Roy bioRxiv, 2020.2009. 2010.292086, 2020 | 3 | 2020 |
| Single-cell transcriptomes and T cell receptors of vaccine-expanded apolipoprotein B-specific T cells FS Nettersheim, Y Ghosheh, H Winkels, K Kobiyama, C Durant, ... Frontiers in Cardiovascular Medicine 9, 1076808, 2023 | 2 | 2023 |
| Blind Spot: 18F-FDG PET Fails to Reveal Atherosclerosis Aggravated by Cancer Immunotherapy K Ley, P Roy Cardio Oncology 2 (4), 611-613, 2020 | 2 | 2020 |
